<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Mon, 09 Nov 2009 06:05:37 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Week in Review: Summer Slump for News</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2439907</guid>
      <description><![CDATA[The news flow from the China biomedical sector slowed considerably&#160;last week, probably the summer doldrums. We published the second part of our guest article that updates proposed patent law changes.&#160;&#160;GSK completed an unusual&#160;deal with generic manufacturer, Aspen PharmaCare; MedMira received a China patent for its diagnostic device and assay; GNI Ltd. of Japan in-licensed a late-stage hepatitis drug from EpiCept; and Genelabs Technologies will collaborate with Taiwan’s National Health Research Institutes and Genovate Biotechnology of Taiwan to develop drugs for hepatitis C virus.&#160; More details... Stock Symbols: (NYSE: GSK) (NSDQ:&#160;MMIRF) (TOKYO: 2160) (NSDQ: EPCT) (NSDQ: GNLB)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2439907>[More...]</a>]]></description>
      <pubDate>Sun, 27 Jul 2008 17:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GNLB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2439907</link>
    </item>
    <item>
      <title>MedMira Granted China Patent for Diagnostic Device</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2422549</guid>
      <description><![CDATA[MedMira Inc., a Canadian company, received a China patent for its rapid diagnostic device and assay (Chinese Patent Application No. 02819646.5). The patents covers the rapid flow-through technology (RFT) platform on which the company has built its line of<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2422549>[More...]</a>]]></description>
      <pubDate>Wed, 23 Jul 2008 01:17:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TSX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2422549</link>
    </item>
    <item>
      <title>MedMira and Triplex to Launch Five New Rapid Tests in Mainland China and Hong Kong for Infectious Diseases, STDs, and Drugs of Abuse</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3435075</guid>
      <description><![CDATA[HALIFAX, Aug. 25 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that it is expanding its product line with strategic partner, Triplex International Biosciences Co., Ltd. (Triplex), in Mainland China and Hong Kong. The partners are moving forward with SFDA regulatory submissions and subsequent market launch for rapid tests under the Multiplo brand including the HBV/HIV/HCV rapid test and combination tests for HIV and syphilis and HIV and tuberculosis.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3435075>[More...]</a>]]></description>
      <pubDate>Tue, 25 Aug 2009 13:10:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3435075</link>
    </item>
    <item>
      <title>MedMira Announces Draw Down of Equity Line</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3430491</guid>
      <description><![CDATA[HALIFAX, Aug. 21 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that it has submitted a draw down notice for $150,000 to YA Global Investments LP against its equity line of credit. The capital available through the draw down on the equity line of credit enables MedMira to support its ongoing global sales and business development action plans.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3430491>[More...]</a>]]></description>
      <pubDate>Fri, 21 Aug 2009 20:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3430491</link>
    </item>
    <item>
      <title>MedMira Announces Settlement of Debt</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3416352</guid>
      <description><![CDATA[HALIFAX, Aug. 14 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that that it has reached an agreement with debt holders to settle a total of $966,087 owing for debts to the Company through the issuance of 14,862,880 common shares. The Company will issue common shares at a price of $0.065 per share based on the August11, 2009 closing price. This agreement is subject to the approval of the TSX Venture Exchange. Shares issued under this agreement will be subject to a four month hold period.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3416352>[More...]</a>]]></description>
      <pubDate>Fri, 14 Aug 2009 20:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3416352</link>
    </item>
    <item>
      <title>MedMira Introduces Expanded Multiplo(TM) Product Line at US Military Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3405681</guid>
      <description><![CDATA[HALIFAX, Aug. 10 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today the introduction of new Multiplo(TM) rapid tests at the US Military's Advanced Technology Applications for Casualty Combat Care (ATACCC) Conference taking place this week in St. Pete's Beach, FL.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3405681>[More...]</a>]]></description>
      <pubDate>Mon, 10 Aug 2009 12:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3405681</link>
    </item>
    <item>
      <title>MedMira Announces Completion of Equity Line Draw Down</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3402846</guid>
      <description><![CDATA[HALIFAX, Aug. 7 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that it has completed the draw down against its equity line of credit with YA Global Investments LP which was announced on August 4, 2009. MedMira will use this capital to support new and ongoing sales and business development action plans.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3402846>[More...]</a>]]></description>
      <pubDate>Fri, 07 Aug 2009 20:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3402846</link>
    </item>
    <item>
      <title>MedMira Announces Draw Down of Equity Line</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3391631</guid>
      <description><![CDATA[HALIFAX, Aug. 4 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that it has submitted (July 20, 2009) a draw down notice for $150,000 to YA Global Investments LP against its equity line of credit. The capital available through the draw down on the equity line of credit enables MedMira to support its ongoing global sales and business development action plans.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3391631>[More...]</a>]]></description>
      <pubDate>Tue, 04 Aug 2009 19:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3391631</link>
    </item>
    <item>
      <title>MedMira Announces Approval of Settlement of Debt</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3371002</guid>
      <description><![CDATA[HALIFAX, July 24 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF) a developer and marketer of rapid diagnostics, announced today that further to the news release issued June 5, 2009, it has received approval from the TSX Venture Exchange to settle $479,431 of debt through the issuance of common shares. The Company will issue 6,849,011 common shares at a price of $0.07 per share based on the June 4, 2009 close. Shares issued under this agreement will be subject to a four month hold period.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3371002>[More...]</a>]]></description>
      <pubDate>Fri, 24 Jul 2009 20:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3371002</link>
    </item>
    <item>
      <title>MedMira Enters Strategic Partnership with Triplex International Biosciences to Accelerate Growth in China</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3324255</guid>
      <description><![CDATA[HALIFAX, June 30 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that it is making progress on market development in China through the creation of a strategic partnership with Triplex International Biosciences Co., Ltd. (Triplex), a major player in China's diagnostics sector.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3324255>[More...]</a>]]></description>
      <pubDate>Tue, 30 Jun 2009 13:36:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3324255</link>
    </item>
    <item>
      <title>MedMira Announces Third Quarter Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3320081</guid>
      <description><![CDATA[HALIFAX, June 29 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, today announced its financial results for the three and nine month periods ending April 30, 2009. Product sales in the third quarter were $329 thousand, compared to $400 thousand in the same quarter last year. The net loss for the quarter was $976,930 or $0.01 per share compared with a net loss of $1.4 million or $0.02 per share in the same period last year.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3320081>[More...]</a>]]></description>
      <pubDate>Mon, 29 Jun 2009 20:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3320081</link>
    </item>
    <item>
      <title>MedMira Announces Appointment to Board of Directors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3189330</guid>
      <description><![CDATA[HALIFAX, April 9 /CNW/ - MedMira Inc., (&quot;MedMira&quot;) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, today announced the appointment of Mr. Andre Archimbaud to the Company's Board of Directors.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3189330>[More...]</a>]]></description>
      <pubDate>Thu, 09 Apr 2009 20:10:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMIRF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3189330</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=MMIRF" rel="self" type="application/rss+xml" />
  </channel>
</rss>